Holen Sie sich die Stockscreener-App
14.77
0.94%
-0.14
Handel nachbörslich:
14.71
-0.06
-0.41%
Schlusskurs vom Vortag:
$14.91
Offen:
$14.98
24-Stunden-Volumen:
772.22K
Relative Volume:
0.73
Marktkapitalisierung:
$1.07B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.81M
KGV:
-29.55
EPS:
-0.4998
Netto-Cashflow:
$-122.54M
1W Leistung:
+0.68%
1M Leistung:
+35.50%
6M Leistung:
+111.30%
1J Leistung:
+116.89%
1-Tages-Spanne:
$14.63
$15.05
1-Wochen-Bereich:
$14.37
$15.32
52-Wochen-Spanne:
$2.95
$17.65
Omeros Corp Stock (OMER) Company Profile
Firmenname
Omeros Corp
Sektor
Branche
Telefon
206-676-5000
Adresse
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Compare OMER vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMER
Omeros Corp
|
14.77 | 1.08B | 0 | -4.81M | -122.54M | -0.4998 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Omeros Corp Stock (OMER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-23 | Eingeleitet | D. Boral Capital | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-12-08 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-06-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-10-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2021-10-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2021-09-27 | Eingeleitet | JP Morgan | Neutral |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-20 | Eingeleitet | BofA Securities | Buy |
| 2020-08-21 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-14 | Bestätigt | Maxim Group | Buy |
| 2019-05-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-07-12 | Eingeleitet | Seaport Global Securities | Buy |
| 2018-03-23 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-03-05 | Herabstufung | Needham | Buy → Hold |
| 2017-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Herabstufung | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | Bestätigt | Maxim Group | Buy |
| 2017-03-17 | Bestätigt | Needham | Buy |
| 2016-11-16 | Bestätigt | Wedbush | Outperform |
| 2016-11-10 | Bestätigt | Needham | Buy |
| 2016-08-10 | Bestätigt | Maxim Group | Buy |
| 2016-06-03 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-02 | Bestätigt | Needham | Buy |
| 2016-02-29 | Bestätigt | Wedbush | Outperform |
| 2015-11-11 | Bestätigt | Needham | Buy |
| 2015-08-18 | Bestätigt | WBB Securities | Strong Buy |
| 2015-08-10 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Omeros Corp Aktie (OMER) Neueste Nachrichten
Omeros (NASDAQ:OMER) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
OMEROS CORP ($OMER) CEO 2025 Pay Revealed - Quiver Quantitative
OMER Forecast, Price Target & Analyst Ratings | OMEROS CORP (NASDAQ:OMER) - ChartMill
Executive pay, incentives and votes detailed in Omeros (NASDAQ: OMER) 2026 proxy - Stock Titan
[ARS] OMEROS CORP SEC Filing - Stock Titan
OMER stock on track for best week in nearly 4 months after receiving permanent reimbursement code for treatment - MSN
Omeros rises as Novo deal boosts Q4 earnings - MSN
OMER stock surges 5% after hours on Novo Nordisk deal windfall and drug launch optimism - MSN
Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway - Yahoo Finance
Omeros Stock Logs Best Session Ever After HC Wainwright Doubles Target On Novo Nordisk Deal; Retail Sees Big Upside - MSN
Omeros (NASDAQ:OMER) Trading 6.3% HigherShould You Buy? - MarketBeat
Here's Why Omeros (OMER) is a Great Momentum Stock to Buy - Yahoo Finance
Wall Street Analysts Believe Omeros (OMER) Could Rally 222.76%: Here's is How to Trade - Yahoo Finance
Omeros (NASDAQ:OMER) Lowered to Hold Rating by Wall Street Zen - MarketBeat
how Fair Value analysis identified Omeros’ 74% biotech breakout By Investing.com - Investing.com South Africa
how Fair Value analysis identified Omeros’ 74% biotech breakout - Investing.com
Omeros Q4 2025 earnings preview - MSN
OMER Stock Price, Quote & Chart | OMEROS CORP (NASDAQ:OMER) - ChartMill
Omeros Corporation to acquire $80.5 million of its convertible senior notes due 2026 - MSN
Ingalls & Snyder (NASDAQ: OMER) holds 3.47M shares, 4.8% stake - Stock Titan
OMER (Omeros Corporation) shares rise 7.18 percent after Q4 2025 earnings sharply outperform analyst estimates.Hot Momentum Watchlist - Xã Thanh Hà
OMER Maintained by D. Boral Capital -- Price Target Remains at $36 - GuruFocus
Omeros Is Maintained at Buy by D. Boral Capital - Moomoo
D. Boral Capital Reiterates "Buy" Rating for Omeros (NASDAQ:OMER) - MarketBeat
Sagimet Biosciences (SGMT) CMO retires as company appoints successor - Stock Titan
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer - GlobeNewswire Inc.
OMER Stock On Track For Best Week In Nearly 4 Months After Receiving Permanent Reimbursement Code For Treatment - Stocktwits
Omeros (NASDAQ:OMER) Rating Increased to Buy at Wall Street Zen - MarketBeat
Omeros CorporationCMS Assigns Permanent Reimbursement J-Code for YARTEMLEA - marketscreener.com
Omeros receives permanent J-code for TA-TMA treatment Yartemlea By Investing.com - Investing.com India
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug) - BioSpace
Omeros (OMER) Secures Permanent J-Code for YARTEMLEA - GuruFocus
Omeros says CMS assigns permanent reimbursement J-code for YARTEMLEA - TipRanks
Finanzdaten der Omeros Corp-Aktie (OMER)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):